A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

NCT02754882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

763

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Non-small Cell Lung Cancer

Interventions

DRUG: Bevacizumab
DRUG: SB8
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Samsung Bioepis Co., Ltd.